Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

13.0K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.0K
Molecular Models02:00

Molecular Models

38.9K
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
38.9K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
Protein-Drug Binding: Determination Methods01:22

Protein-Drug Binding: Determination Methods

255
Determining protein-drug binding can be achieved through indirect and direct methods, each providing valuable insights into the interaction between proteins and drugs.
Indirect methods involve isolating the bound drug from its free form in biological samples such as blood, serum, or plasma. These techniques aim to measure the percentage of drugs bound to proteins. Equilibrium dialysis is a commonly used method where the free drug concentration at equilibrium is measured by separating the bound...
255
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

13.1K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic and structural characterisation of alzheimer's disease associated variants in an Eastern Indian cohort.

Metabolic brain disease·2026
Same author

The endoplasmic reticulum protein FAM134B acts as a regulator of mitochondrial morphology.

Journal of cell science·2025
Same author

The impact of ER<sup>UPR</sup> on mitochondrial integrity mediated by PDK4.

Cell death & disease·2025
Same author

The mRNA-capping enzyme localizes to stress granules in the cytoplasm and maintains cap homeostasis of target mRNAs.

Journal of cell science·2024
Same author

EIF4A3 targeted therapeutic intervention in glioblastoma multiforme using phytochemicals from Indian medicinal plants - an integration of phytotherapy into precision onco-medicine.

Journal of biomolecular structure & dynamics·2024
Same author

CMT2A-linked MFN2 mutation, T206I promotes mitochondrial hyperfusion and predisposes cells towards mitophagy.

Mitochondrion·2023

Related Experiment Video

Updated: Aug 9, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

438

MetaDOCK: A Combinatorial Molecular Docking Approach.

Izaz Monir Kamal1,2, Saikat Chakrabarti1,2

  • 1Division of Structural Biology & Bioinformatics, CSIR-Indian Institute of Chemical Biology, Salt Lake, Sector V, Kolkata 700032, India.

ACS Omega
|February 23, 2023
PubMed
Summary

A new meta-docking protocol combines multiple free software tools to improve drug discovery accuracy. This consensus approach enhances molecular docking reliability for researchers without access to expensive commercial packages.

More Related Videos

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

195
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Related Experiment Videos

Last Updated: Aug 9, 2025

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

438
Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins
05:08

Application of I TASSER, trRosetta, UCSF Chimera, HADDOCK server, and HEX loria for De Novo and In Silico Design of Proteins

Published on: July 8, 2025

195
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.4K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Bioinformatics

Background:

  • Molecular docking is crucial for drug screening but current algorithms need improved reliability to match experimental binding data.
  • Existing docking software often has limitations in scoring, posing, and screening accuracy.

Purpose of the Study:

  • To develop a novel meta-docking protocol by integrating multiple freely available docking tools.
  • To enhance the accuracy and reliability of molecular docking for drug discovery.
  • To provide an accessible alternative to costly commercial docking software.

Main Methods:

  • A meta-docking protocol was created by combining results from AutoDock4.2, LeDock, and rDOCK.
  • Benchmarking analyses evaluated scoring, posing, and screening capabilities against GOLD and PLANTS.
  • Molecular dynamics simulations and free energy estimations were used to assess energetic stability.

Main Results:

  • The MetaDOCK approach demonstrated superior performance in scoring, posing, and screening compared to reference programs.
  • Docking solutions generated by MetaDOCK showed enhanced energetic stability through simulations.
  • The consensus strategy effectively captured complementary strengths of individual docking programs.

Conclusions:

  • The MetaDOCK protocol offers a reliable and cost-effective solution for molecular docking in drug discovery.
  • This approach significantly improves the prediction of protein-ligand interactions.
  • It serves as a valuable alternative for academic and industrial researchers lacking commercial software budgets.